Neurologic Disorders Resource Center

Click on the subcategory below to find drug monographs for that particular area.

Depression Risk, Parkinson's Disease

Untreated patients in the early stages of Parkinson's disease are more likely to experience neuropsychiatric symptoms such as depression.

Child Neurodevelopment Disability Up

There has been a 20.9% increase in child disability cases related to any neurodevelopment or mental health condition since 2001.

Cognitive Function and Stroke Risk

Lower cognitive function is associated with increased risk of stroke in older adults, and cognitive decline increases after stroke vs. before stroke.

Wearable Cameras Help with Memory

Wearable cameras could help in both event recall and improvement to brain functioning and memory in patients with amnesia and dementia.

Fish Once-a-Week and Cognitive Decline

It may only take eating one portion of fish once a week to gain protective benefits against cognitive decline, including Alzheimer’s disease.

HIV Linked to Lower MS Risk

HIV infection is associated with a significantly decreased risk of developing multiple sclerosis (MS).

Vitamin D and Alzheimer's Disease

Low concentrations of serum 25-hydroxyvitamin D (25[OH]D) may increase the risk of developing all-cause dementia and Alzheimer's disease.

Chart: Multiple Sclerosis Treatments

Review this new chart on multiple sclerosis treatments for quick information when you need it.

Videos

News

Nuplazid Designated Breakthrough Therapy for Parkinson's Disease Psychosis

The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to Nuplazid (pimavanserin; Acadia Pharmaceuticals) for the treatment of Parkinson's disease psychosis.

Vimpat Gains Monotherapy Indication for Seizures

UCB announced that the Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for Vimpat (lacosamide) as monotherapy in the treatment of partial-onset seizures in patients with epilepsy aged >17 years.

Multiple Sclerosis and Salt: Symptoms May Worsen with High Intake

High sodium intake is associated with increased disease activity in multiple sclerosis (MS), with exacerbated disease activity and a higher risk of new lesions on MRI observed in the high-sodium group.

Teens Regress After Return-to-Activity Post-Concussion

High school athletes who return to the field with medical clearance within 60 days experience a significant regression in their abilities to simultaneously walk and do simple mental tasks.

FEATURES

Nuplazid Designated Breakthrough Therapy for Parkinson's Disease Psychosis

The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to Nuplazid (pimavanserin; Acadia Pharmaceuticals) for the treatment of Parkinson's disease psychosis.

Vimpat Gains Monotherapy Indication for Seizures

Vimpat Gains Monotherapy Indication for Seizures

UCB announced that the Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for Vimpat (lacosamide) as monotherapy in the treatment of partial-onset seizures in patients with epilepsy aged >17 years.

Multiple Sclerosis and Salt: Symptoms May Worsen with High Intake

Multiple Sclerosis and Salt: Symptoms May Worsen with High Intake

High sodium intake is associated with increased disease activity in multiple sclerosis (MS), with exacerbated disease activity and a higher risk of new lesions on MRI observed in the high-sodium group.

Featured courses from mycme

UCLA Review of Clinical NeurologyExternal web site

Led by Course Chair Alon Avidan, MD, MPH, the authoritative faculty of The UCLA Review ...

CME 23.00 Credits

A 70-Year-Old Woman With Altered Cognition and Emotional LabilityExternal web site

Several illnesses may cause dementia, including dementia with Lewy bodies (DLB), Pick’s disease and other ...

CME 0.50 Credits

MS: Focus on Neurodegeneration and NeuroprotectionExternal web site

This CME-certified roundtable discussion enables learners to strengthen their knowledge of the potential neuroprotective strategies ...

CME 1.25 Credits

Sign Up for Free e-newsletters